---
title: "Cartesian Therapeutics (RNAC.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/RNAC.US/norm.md"
symbol: "RNAC.US"
name: "Cartesian Therapeutics"
parent: "https://longbridge.com/zh-CN/quote/RNAC.US.md"
datetime: "2026-06-13T22:35:30.915Z"
locales:
  - [en](https://longbridge.com/en/quote/RNAC.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RNAC.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RNAC.US/norm.md)
---

# Cartesian Therapeutics (RNAC.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -1.46 | -3.56 | -1.38 | 0.5000 | -0.6837 |
| ROE | 114.25% | 456.93% | 748.52% | -436.19% | 495.54% |
| 营业收入 | 78000.00 | 947000.00 | 452000.00 | 298000.00 | 1.10M |
| 净利润 | -39.18M | -92.58M | -35.90M | 13.26M | -17.71M |
| 营业利润 | -26.50M | -21.94M | -21.07M | -21.81M | -21.89M |
| 毛利率 | -24852.56% | -1451.11% | -2953.54% | -4889.60% | -1234.00% |
| 净利率 | -50233.33% | -9775.71% | -7942.92% | 5330.87% | -1610.00% |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 288.39M | 296.41M | 372.68M | 388.89M | 409.13M |
| 权益乘数 | -1.95 | -2.35 | -10.40 | -153.90 | -18.78 |
| 每股净资产 | -5.19 | -4.85 | -1.38 | -0.0972 | -0.8401 |
| 资产周转率 | 0.0051 | 0.0076 | 0.0026 | 0.0028 | 0.0931 |
| 现金及短投 | 118.64M | 125.14M | 143.38M | 160.32M | 180.43M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 17.00M | 17.79M | 17.37M | 17.45M | 15.53M |
| 净债务 | -106.79M | -112.46M | -130.78M | -146.97M | -166.37M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -22.14M | -17.71M | -15.60M | -17.52M | -23.11M |
| 投资现金流 | -27000.00 | -492000.00 | -1.29M | -2.60M | -1.07M |
| 融资现金流 | 15.67M | -52000.00 | -38000.00 | 60000.00 | -8.03M |
| 自由现金流 | -11.84M | -10.85M | -10.61M | -13.57M | -20.59M |
| 现金流充裕率 | -81981.48% | -3600.00% | -1207.43% | -675.18% | -2149.58% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | -27000.00 | -492000.00 | -1.29M | -2.60M | -1.07M |